| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Genetics | 77 | 46 | 33 | 12 |
| Medicine | 1309 | 164 | 83 | 18 |
The journal is organized to address concerns in the fields of Internal medicine, Pharmacology, Pharmacogenetics, Genetics and Genotype. In addition to Internal medicine research, it aims to explore topics under Gastroenterology, Endocrinology, Single-nucleotide polymorphism and Oncology. While Pharmacogenomics Journal focused on Oncology, it was also able to explore topics like Chemotherapy, Immunology, Hazard ratio, Colorectal cancer and Cohort.
Pharmacology study tackled is connected to the field of CYP2D6. Adverse effect, Pharmacogenomics, Bioinformatics and Intensive care medicine are some topics wherein Pharmacogenetics research discussed in it have an impact. Most of the Bioinformatics studies addressed also intersect with Drug development.
It concentrated on Genetics research, specifically Gene, Allele frequency, Haplotype, Genetic variation and Genetic association. Pharmacogenomics Journal features studies on Gene, including topics such as Gene expression. The in-depth study on Genotype also explores topics in the intersecting field of Allele.
The published articles focus on Pharmacology, Internal medicine, Pharmacogenetics, Genetics and Genotype. While Internal medicine is the focus of the most cited papers, it also provides insights into the studies of Gastroenterology, Endocrinology, Immunology and Oncology. The most cited publications explore research in Genotype alongside concepts in Allele and other areas of study in Genetic variation.
The objective of Pharmacogenomics Journal is to combine knowledge in the areas of Internal medicine, Oncology, Genotype, Pharmacogenetics and Pharmacogenomics. Internal medicine research presented in the journal encompasses a variety of subjects, including Genotyping, Single-nucleotide polymorphism, Gastroenterology and Polymorphism (computer science). Aside from discussions in Oncology, the journal also deals with the subject of Prostate cancer which intersects with Lower risk disciplines.
The research on Genotype featured in it combines topics in other fields like Irinotecan, Adverse effect and Chemotherapy. The study of CYP2C19 and how it intertwines with concepts under Clopidogrel, CYP2D6 and Allele were explored in the presented Pharmacogenetics research. Pharmacogenomics Journal focuses on Pharmacogenomics but sometimes tackles the closely related topic of MEDLINE which is concerned with Medical prescription.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Pharmacogenomics Journal (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Pharmacogenomics Journal (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 2.56% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 7.89% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.53% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.79% of all publications and 65.79% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Mustafa Adnan Malki;Ewan Robert Pearson
(2020)Xiao Chen;Fei Shen;Nina Gonzaludo;Alka Malhotra
(2021)Eleanor M Wigmore;Jonathan D Hafferty;Lynsey S Hall;David M Howard
(2020)Dorothea Lesche;Sam Mostafa;Ian Everall;Christos Pantelis;Christos Pantelis;Christos Pantelis
(2020)Eva Clemens;Linda Broer;Thorsten Langer;André G. Uitterlinden
(2020)Limdi Na;Cavallari Lh;Lee Cr;Hillegass Wb
(2020)Eva Rye Rasmussen;Eva Rye Rasmussen;Pär Hallberg;Ekaterina V. Baranova;Niclas Eriksson
(2020)For those interested in healthcare but not ready for the demands of medical school, several online degree options offer alternative career paths. Programs like accelerated radiology tech programs online provide a fast-track route to becoming a radiologic technologist, combining affordability with flexibility.
Nutrition professionals can explore dietetic masters programs which focus on advanced dietary science and public health, opening doors to specialized careers in clinical dietetics and community nutrition planning.
Financial considerations are crucial when pursuing healthcare education. Many students benefit from discovering financial aid for medical assistant programs, helping reduce the burden of tuition fees and allowing a focus on studies.
Additionally, those already working as medical assistants might consider upgrading their qualifications through ma to lpn programs online, providing an efficient way to advance into licensed practical nursing with flexible scheduling.
These pathways highlight the diverse options available for pursuing a career in healthcare related to medicine in the USA, catering to different goals, timeframes, and financial situations.
